Startseite Urinary Plasma Protein Patterns in Acute Prostatitis
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Urinary Plasma Protein Patterns in Acute Prostatitis

  • Karel Everaert , Joris Delanghe , Marc Vanderkelen , Kristof Cornelis , Stefaan De Wachter , Annick Viaene , Eddy De Ruyck , Bart Clarysse und Willem Oosterlinck
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 41 Heft 1

Abstract

We evaluated the diagnostic utility of urinary α1-microglobulin, α2-macroglobulin and albumin in the diagnosis of acute prostatitis. We studied 133 men (43±17 years) with, and a reference population (n=36, 41±16 years) without, urinary tract infection. Prostatectomy samples were used to study the potential interference between prostatic proteins and protein analysis. Urinary α2-macroglobulin/albumin ratio was significantly lower in prostatitis compared to the reference population, cystitis or acute pyelonephritis (p <0.0001). Low α2-macroglobulin concentrations in prostatitis are due to inhibition (p = 0.0001) of the immune reaction between α2-macroglobulin in presence of polyclonal rabbit antibodies (used for immunonephelometry) by soluble prostatic proteins (± 60 kDa) which appear in urine in acute prostatitis. The urinary α1-microglobulin/creatinine ratio diagnoses acute pyelonephritis (sensitivity 100% and specificity 87%) and the urinary α2-macroglobulin/albumin ratio diagnoses acute prostatitis (sensitivity 100% and specificity of 90%). Stepwise multinomial logistic regression analysis reveals that urinary α1-microglobulin, α2-macroglobulin, albumin and creatinine provide optimal differentiation between acute pyelonephritis and acute prostatitis (pseudo R2=0.83; Loglikelihood −30.55, p <0.000001). In conclusion, the combination of hematuria and absence of urinary alpha-2-macroglobulin is diagnostic for acute prostatitis. Even without hematuria, α2-macroglobulin remains lower compared to patients without prostatitis.

:
Published Online: 2005-06-01
Published in Print: 2003-01-27

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. Evidence-Based Laboratory Medicine: Addressing Bias, Generalisability and Applicability in Studies on Diagnostic Accuracy. The STARD Initiative
  2. Semen Polymorphonuclear Neutrophil Leukocyte Elastase as a Diagnostic and Prognostic Marker of Genital Tract Inflammation – A Review
  3. Total Oxyradical Scavenging Capacity toward Different Reactive Oxygen Species in Seminal Plasma and Sperm Cells
  4. Identification of New Polymorphisms in the CACNA1S Gene
  5. 3-Nitrotyrosine in Atherosclerotic Blood Vessels
  6. Molecular Diagnosis of Cystic Fibrosis: Comparison of Four Analytical Procedures
  7. Assessment of Intestinal Permeability: Enzymatic Determination of Urinary Mannitol, Raffinose, Sucrose and Lactose on Hitachi Analyzer
  8. Effects of Calcium Carbonate, Magnesium Oxide and Sodium Citrate Bicarbonate Health Supplements on the Urinary Risk Factors for Kidney Stone Formation
  9. Glycerol Metabolism and the Determination of Triglycerides –Clinical, Biochemical and Molecular Findings in Six Subjects
  10. Plasma Lipid Composition and LDL Oxidation
  11. Modified Method to Measure Nasal Potential Difference
  12. Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
  13. Novel and Traditional Biomarkers of Bone Turnover in Postmenopausal Women
  14. Urinary Plasma Protein Patterns in Acute Prostatitis
  15. Adequate Sampling in Cryoglobulinaemia: Recommended Warmly
  16. A New Modification of the Chiron ACS Assay for Total Prostate-Specific Antigen Achieves Equimolar Response Characteristics and Improves the Detection of Prostate Cancer
  17. Technical Performance and Diagnostic Utility of the New Elecsys® Neuron-Specific Enolase Enzyme Immunoassay
  18. Measurements of Complement Factor H-Related Protein (BTA-TRAK™ Assay) and Nuclear Matrix Protein (NMP22 Assay) – Useful Diagnostic Tools in the Diagnosis of Urinary Bladder Cancer?
  19. Erratum: The 18th International Congress of Clinical Chemistry and Laboratory Medicine. Special Supplement Abstracts Issue 2002
  20. Meetings and Awards
Heruntergeladen am 29.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2003.014/html
Button zum nach oben scrollen